This study will be the initial exploration of APL-2 in patients with PNH. The assessments of the safety, tolerability, PK, and PD following administration of single and multiples doses of APL-2 will guide decisions to further develop the drug.
The purpose of this study is to determine the overall safety of adoptive immunotherapy when given after
No abstract available.
The purpose of this study is to test the effects, good and/or bad, of the investigational product, GL-ONC1, alone or in combination with
The are a variety of cancerous diseases of the blood and bone marrow that can be potentially cured by bone marrow transplantation (BMT). Diseases like leukemia, lymphoma, and multiple myeloma are among the conditions that can be treated with BMT.
Allogeneic transplant from a matched sibling for the treatment of a variety of illnesses including
The purpose of this study is to provide an opportunity for patients with malignancies or